Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause


Author(s): Robeva R, Mladenović D, Vesković M, Hrnčić D, Bjekić-Macut J, Stanojlović O, Livadas S, Yildiz BO, Macut D
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: NAFLD in postmenopausic women
Publication: Maturitas v151 p22-30 Year: 2021 ORPHAcode / other:
DOI: 10.1016/j.maturitas.2021.06.012 Keywords: dyslipidemia,estrogen,insulin resistance,menopausal hormonal therapy,menopause,non-alcoholic fatty liver disease

Children with multiple endocrine neoplasia type 2B: Not tall and marfanoid, but short with normal body proportions


Author(s): van den Broek MFM, van Santen HM, Valk GD, Verrijn Stuart AA
Affiliated Institution / ERN: University Medical Center Utrecht ;
Condition / Disease: Multiple endocrine neoplasia type 2B
Publication: Clinical Endocrinology v95.3 p453-459 Year: 2021 ORPHAcode / other: ORPHA247709
DOI: 10.1111/cen.14536 Keywords: final height,growth,marfanoid body habitus,multiple endocrine neoplasia type 2B,short stature
MTG4

Adolescent and Young Adult Urogenital Outcome following Childhood Hypospadias Repair: Perfection Revisited


Author(s): Tack LJW, Springer A, Riedl S, Tonnhofer U, Hiess M, Weninger J, Mahmoud A, Van Laecke E, Hoebeke P, Cools M, Spinoit A
Affiliated Institution / ERN: Ghent University Hospital ; Medical University of Vienna,Center for Rare Diabetes and Congenital Hyperinsulinism / Dpt. of Pedia ; Medical University of Vienna,Center for Rare Endocrinologic Diseases / Dpt. of Internal Medicine III ;
Condition / Disease: Non-syndromic hypospadias
Publication: Journal of Urology v206.3 p734-744 Year: 2021 ORPHAcode / other: LB53
DOI: 10.1097/JU.0000000000001869 Keywords: hypospadias,treatment outcome,urologic surgical procedures, male

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?


Author(s): Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC
Affiliated Institution / ERN: IRCCS Auxologico Italian Institute - Milan ; AO City of Health and Science - Turin ; Antonio Cardarelli Hospital - Naples ; ERN BOND ;
Condition / Disease: Neuroendocrine neoplasm
Publication: Reviews in Endocrine and Metabolic Disorders v22.3 p511-525 Year: 2021 ORPHAcode / other: ORPHA877
DOI: 10.1007/s11154-020-09589-y Keywords: Cytokines,Inflammation,Microbiota,Neuroendocrine tumors,Tumor microenvironment

Occurrence of pituitary hormone deficits in relation to both pituitary and hypothalamic doses after radiotherapy for skull base meningioma


Author(s): Partoune E, Virzi M, Vander Veken L, Renard L, Maiter D
Affiliated Institution / ERN: University Hospitals Saint-Luc ;
Condition / Disease: Meningioma
Publication: Clinical Endocrinology v95.3 p460-468 Year: 2021 ORPHAcode / other: ORPHA2495
DOI: 10.1111/cen.14499 Keywords: brain tumour,endocrine deficit,hypopituitarism,hypothalamus,pituitary,radiotherapy,skull base meningioma
MTG6

PRRT: identikit of the perfect patient


Author(s): Albertelli M, Dotto A, Di Dato C, Malandrino P, Modica R, Versari A, Colao A, Ferone D, Faggiano A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Reviews in Endocrine and Metabolic Disorders v22.3 p563-579 Year: 2021 ORPHAcode / other:
DOI: 10.1007/s11154-020-09581-6 Keywords: Neuroendocrine tumors,Peptide receptor radionuclide therapy,Predictor,Response,Therapeutic sequence

ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy


Author(s): A Luger, L H A Broersen, N R Biermasz, B M K Biller, M Buchfelder, P Chanson, J O L Jorgensen, F Kelestimur, S Llahana, D Maiter, G Mintziori, F Petraglia, R Verkauskiene, S M Webb, O M Dekkers
Affiliated Institution / ERN:
Condition / Disease:
Publication: European Journal of Endocrinology 185(3):G1-G33. doi: 10.1530/EJE-21-0462 Year: 2021 ORPHAcode / other:
DOI: Keywords:
MTG6

Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery


Author(s): de Vries F, Lobatto DJ, Verstegen MJT, Schutte PJ, Notting IC, Kruit MC, Ahmed SF, Pereira AM, van Furth WR, Biermasz NR
Affiliated Institution / ERN: Leiden University Medical Center ;
Condition / Disease: Functioning pituitary adenoma
Publication: The Journal of Clinical Endocrinology & Metabolism v106.9 pe3300-e3311 Year: 2021 ORPHAcode / other: ORPHA314753
DOI: 10.1210/clinem/dgab138 Keywords: Pituitary adenoma,outcomes,patient counselling,transsphenoidal surgery
MTG6

Hyperprolactinemia in Adults with Prader-Willi Syndrome


Author(s): Sjöström A, Pellikaan K, Sjöström H, Goldstone AP, Grugni G, Crinò A, De Graaff LCG, Höybye C
Affiliated Institution / ERN: Karolinska University Hospital ; Erasmus MC: University Medical Center Rotterdam ; IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Prader-Willi syndrome
Publication: Journal of Clinical Medicine v10.16 p3613 Year: 2021 ORPHAcode / other: ORPHA739
DOI: 10.3390/jcm10163613 Keywords: Prader-Willi syndrome,adults,hyperprolactinemia,hypogonadism
MTG5

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study


Author(s): García-Escobar E, Valdés S, Soriguer F, Vendrell J, Urrutia-Etxebarria IM, Maldonado-Araque C, Ortega E, Ocón P, Montanya E, Menéndez E, Lago-Sampedro A, González-Frutos T, Gomis R, Goday A, García-Serrano S, Galán-García JL, Castell C, Bordiú E, Badía R, Aguilera-Venegas G, Girbés J, Gaztambide S, Delgado E, Chaves FJ, Castaño L, Calle-Pascual A, Rojo-Martínez G, Franch-Nadal J
Affiliated Institution / ERN: Hospital Universitario Cruces ;
Condition / Disease: Type 2 diabetes mellitus
Publication: Scientific Reports v11.1 Year: 2021 ORPHAcode / other: 5A10
DOI: 10.1038/s41598-021-95546-x Keywords:
MTG3

Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas


Author(s): Eijkelenkamp K, Osinga TE, van Faassen M, Kema IP, Kerstens MN, Pacak K, Sluiter WJ, Links TP, van der Horst-Schrivers ANA
Affiliated Institution / ERN: University Hospital Essen ; Ulm University Medical Center ;
Condition / Disease: Pheochromocytomas and Paragangliomas
Publication: Clinical Chemistry v67.8 p1090-1097 Year: 2021 ORPHAcode / other: ORPHA573163
DOI: 10.1093/clinchem/hvab064 Keywords:
MTG1 MTG4

Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group


Author(s): Klein Haneveld MJ, van Treijen MJC, Pieterman CRC, Dekkers OM, van de Ven A, de Herder WW, Zandee WT, Drent ML, Bisschop PH, Havekes B, Vriens MR, Verrijn Stuart AA, Valk GD, van Leeuwaarde RS
Affiliated Institution / ERN: University Medical Center Utrecht ; Leiden University Medical Center ; Radboud University Medical Centre Nijmegen ; Erasmus MC: University Medical Center Rotterdam ; University Medical Center Groningen ; Amsterdam UMC ; Maastricht University Medical Center+ ;
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: The Journal of Clinical Endocrinology & Metabolism doi:10.1210/clinem/dgab569 Year: 2021 ORPHAcode / other: ORPHA652
DOI: 10.1210/clinem/dgab569 Keywords: age-related penetrance,multiple endocrine neoplasia type 1,pancreatic NET,surveillance
MTG4

Thiamine-Responsive Megaloblastic Anemia-Related Diabetes: Long-Term Clinical Outcomes in 23 Pediatric Patients From the DPV and SWEET Registries


Author(s): Warncke K, Prinz N, Iotova V, Dunstheimer D, Datz N, Karges B, Jali MV, Linsenmeyer D, Olsen BS, Seiwald M, Prahalad P, de Sousa G, Pacaud D
Affiliated Institution / ERN: Klinikum der Universität München ; Ulm University Medical Center ; UMHAT “Sveta Marina” (Varna) ; Hannoversche Kinderheilanstalt ; University Hospital Aachen ;
Condition / Disease: Diabetes mellitus
Publication: Canadian Journal of Diabetes v45.6 p539-545 Year: 2021 ORPHAcode / other: ORPHA101952
DOI: 10.1016/j.jcjd.2020.11.006 Keywords: anémie mégaloblastique,children,deafness,diabetes,diabète,enfants,megaloblastic anemia,surdité,syndrome,thiamine
MTG3

Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load


Author(s): Atquet V, Alexopoulou O, Maiter D
Affiliated Institution / ERN: University Hospitals Saint-Luc ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v185.2 p313-321 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.1530/EJE-21-0324 Keywords:
MTG6

Methimazole-induced remission rates in pediatric Graves’ disease: a systematic review


Author(s): Lieshout JMv, Mooij CF, Trotsenburg ASPv, Zwaveling-Soonawala N
Affiliated Institution / ERN: Amsterdam UMC ;
Condition / Disease: Paediatric-onset Graves disease
Publication: European Journal of Endocrinology v185.2 p219-229 Year: 2021 ORPHAcode / other: ORPHA525731
DOI: 10.1530/EJE-21-0077 Keywords:
MTG8

Dietary Macronutrient Composition in Relation to Circulating HDL and Non-HDL Cholesterol: A Federated Individual-Level Analysis of Cross-Sectional Data from Adolescents and Adults in 8 European Studies


Author(s): Pinart M, Jeran S, Boeing H, Stelmach-Mardas M, Standl M, Schulz H, Harris C, von Berg A, Herberth G, Koletzko S, Linseisen J, Breuninger TA, Nöthlings U, Barbaresko J, Benda S, Lachat C, Yang C, Gasparini P, Robino A, Rojo-Martínez G, Castaño L, Guillaume M, Donneau A, Hoge A, Gillain N, Avraam D, Burton PR, Bouwman J, Pischon T, Nimptsch K
Affiliated Institution / ERN: Karol Jonscher Clinical Hospital of Poznań University of Medical Sciences ; Klinikum der Universität München ;
Condition / Disease: Nutrition
Publication: The Journal of Nutrition v151.8 p2317-2329 Year: 2021 ORPHAcode / other:
DOI: 10.1093/Jn/Nxab077 Keywords: adolescents,adults,blood lipids,carbohydrates,data integration,data sharing,dietary intake,energy density models,fatty acids,substitution

Active Surveillance for Papillary Thyroid Microcarcinoma in a Population with Restrictive Diagnostic Workup Strategies


Author(s): Lončar I, van Dijk SP, Metman MJ, Lin JF, Kruijff S, Peeters RP, Engelsman AF, van Ginhoven TM
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Thyroid v31.8 p1219-1225 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1089/thy.2020.0845 Keywords: active surveillance,papillary microcarcinoma,thyroid
MTG8

ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases


Author(s): De Herdt C, Philipse E, De Block C
Affiliated Institution / ERN: UZ Antwerpen ;
Condition / Disease: Pituitary adenoma
Publication: European Journal of Endocrinology v185.2 pR65-R74 Year: 2021 ORPHAcode / other: ORPHA99408
DOI: 10.1530/EJE-21-0162 Keywords:
MTG6

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?


Author(s): Giannetta E, La Salvia A, Rizza L, Muscogiuri G, Campione S, Pozza C, Colao AAL, Faggiano A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other:
DOI: 10.3389/fendo.2021.672499 Keywords: PD-L1,VEGF,cytokines,early response,neuroendocrine neoplasms,neutrophil-lymphocyte ratio,platelet-lymphocyte ratio

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer


Author(s): Wirth LJ, Brose MS, Sherman EJ, Licitra L, Schlumberger M, Sherman SI, Bible KC, Robinson B, Rodien P, Godbert Y, De La Fouchardiere C, Newbold K, Nutting C, Misir S, Xie R, Almonte A, Ye W, Cabanillas ME
Affiliated Institution / ERN: CHU d'Angers ; Hospices Civils de Lyon ;
Condition / Disease: Anaplastic Thyroid Carcinoma
Publication: Journal of Clinical Oncology v39.21 p2359-2366 Year: 2021 ORPHAcode / other: ORPHA142
DOI: 10.1200/JCO.20.03093 Keywords:

Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report


Author(s): Del Sindaco G, Berlanga P, Brugières L, Thebault E, Mantovani G, Wicart P, Linglart A
Affiliated Institution / ERN: Hôpital Bicêtre ; ERN BOND ; Reference centre for rare diseases of calcium and phosphate-HEGP ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ; IRCCS Auxologico Italian Institute - Milan ;
Condition / Disease: Aneurysmal Bone Cyst
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA480553
DOI: 10.3389/fendo.2021.698963 Keywords: aneurysmal bone cyst,bisphosphonate,bone modeling,denosumab,hypercalcemia

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study


Author(s): Pivonello R, Bancos I, Feelders RA, Kargi AY, Kerr JM, Gordon MB, Mariash CN, Terzolo M, Ellison N, Moraitis AG
Affiliated Institution / ERN: National Institute of Children's Diseases ; Universitätsklinikum Schleswig-Holstein ;
Condition / Disease: Cushing syndrome
Publication: Frontiers in Endocrinology v12 Year: 2021 ORPHAcode / other: ORPHA553
DOI: 10.3389/fendo.2021.662865 Keywords: Cushing syndrome,clinical trial,cortisol,glucocorticoid,hypercortisolism,hyperglycemia,hypertension,relacorilant
MTG1 MTG6

Do We Need a Specific Guideline for Assessment and Improvement of Acromegaly Patients Adherence?


Author(s): Kamusheva M, Parvanova A, Rusenova Y, Vandeva S, Elenkova A
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: Acromegaly
Publication: Frontiers in Public Health v9 Year: 2021 ORPHAcode / other: ORPHA963
DOI: 10.3389/fpubh.2021.693409 Keywords: Bulgaria,acromegaly,adherence,guideline,health policy
MTG6

G Protein–coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine


Author(s): Suteau V, Seegers V, Munier M, Ben Boubaker R, Reyes C, Gentien D, Wery M, Croué A, Illouz F, Hamy A, Rodien P, Briet C
Affiliated Institution / ERN: IRCCS Ospedale Policlinico San Martino – Genova ;
Condition / Disease: Follicular thyroid carcinoma
Publication: The Journal of Clinical Endocrinology & Metabolism v106.8 p2221-2232 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1210/clinem/dgab343 Keywords: G protein–coupled receptors,Thyroid cancer,follicular,molecular targeted therapies,papillary,prognostic factor,thyroid cancer
MTG8

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1


Author(s): Bastard P, Orlova E, Sozaeva L, Lévy R, James A, Schmitt MM, Ochoa S, Kareva M, Rodina Y, Gervais A, Le Voyer T, Rosain J, Philippot Q, Neehus A, Shaw E, Migaud M, Bizien L, Ekwall O, Berg S, Beccuti G, Ghizzoni L, Thiriez G, Pavot A, Goujard C, Frémond M, Carter E, Rothenbuhler A, Linglart A, Mignot B, Comte A, Cheikh N, Hermine O, Breivik L, Husebye ES, Humbert S, Rohrlich P, Coaquette A, Vuoto F, Faure K, Mahlaoui N, Kotnik P, Battelino T, Trebušak Podkrajšek K, Kisand K, Ferré EM, DiMaggio T, Rosen LB, Burbelo PD, McIntyre M, Kann NY, Shcherbina A, Pavlova M, Kolodkina A, Holland SM, Zhang S, Crow YJ, Notarangelo LD, Su HC, Abel L, Anderson MS, Jouanguy E, Neven B, Puel A, Casanova J, Lionakis MS
Affiliated Institution / ERN: Hospital Universitario Cruces ; ERN BOND ; Karolinska University Hospital ;
Condition / Disease: Autoimmune polyglandular syndrome I
Publication: Journal of Experimental Medicine v218.7 Year: 2021 ORPHAcode / other: ORPHA3453
DOI: 10.1084/jem.20210554 Keywords:
MTG3

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial


Author(s): Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J, Martínez de Soto L, Rodríguez Mariblanca A, Díaz García L, Ramírez García E, Seco Meseguer E, Stewart Balbás SM, Marín Candón A, García García I, Urroz Elizalde M, Monserrat Villatoro J, de la Rosa P, Sanz García M, López Crespo C, Mauleón Martínez V, de Madariaga Castell R, Vitón Vara L, García Rodríguez J, Buño A, López Granados E, Cámara C, Rey Cuevas E, Ayllon García P, Jiménez González M, Hernández Rubio V, Moraga Alapont P, Sánchez A, Prieto R, Llorente Gómez S, Miragall Roig C, Aparicio Marlasca M, de la Calle F, Arsuaga M, Duque B, Meijide S, García de Vicuña A, Santorcuato A, Expósito I, de Benito S, Andia J, Castillo C, Irurzun E, Camino J, Temprano M, Goikoetxea J, Bustinza A, Larrea M, Gallego M, García-Vázquez D, de la Hoz AB, Pérez-Nanclares G, Pérez-Guzmán E, Idoyaga E, Lamela A, Oteo J, Castillo de la Osa M, Hernández Gutiérrez L, Andrés Galván ME, Calonge E, Andrés Galván ME, Bermejo M, de la Torre-Tarazona EH, Cascajero A, Fedele G, Perea C, Cervera I, Bodega-Mayor I, Montes-Casado M, Portolés P, Baranda J, Granés L, Lazaar S, Herranz S, Mellado ME, Tortajada M, Malet M, Quesada S, Vilella A, Llupià A, Olivé V, Trilla A, Gómez B, González E, Romero S, Gámez FJ, Casals C, Burunat L, Castelló JJ, Fernández P, Bedini JL, Vila J, Aguilar C, Altadill C, Armadans L, Borras-Bermejo B, Calonge J, Camacho L, Feliu A, Gili G, Llorente C, Martínez-Gómez X, Otero-Romero S, Palacio E, Parés O, Pinós L, Plaza A, Riera-Arnau J, Rodrigo-Pendás JA, Sans C, Santos J, Torres G, Torrens M, Uriona S, Ballarin Alins E, Pérez Esquirol E, Vendrell Bosch L, Laredo Velasco L, Uribe López D, González Rojano E, Sánchez-Craviotto M, Rivas Paterna AB, Hernán-Gómez TI, Rodríguez Galán N, Gil Marín JA, Álvarez-Morales V, Navalpotro AB, Jiménez-Santamaría MD, Cardós MC, Hermoso E, García-Arenillas M, Pérez Macías N, Domingo Fernández A, López Picado A, Quiñones JM, Deidda N, García-Franco A, Torvisco JM
Affiliated Institution / ERN:
Condition / Disease:
Publication: The Lancet v398.10295 p121-130 Year: 2021 ORPHAcode / other:
DOI: 10.1016/S0140-6736(21)01420-3 Keywords:

Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria


Author(s): Rinke A, Maintz C, Müller L, Weber MM, Lahner H, Pavel M, Saeger W, Houchard A, Ungewiss H, Petersenn S
Affiliated Institution / ERN:
Condition / Disease:
Publication: Experimental and Clinical Endocrinology & Diabetes v129.07 p500-509 Year: 2021 ORPHAcode / other:
DOI: 10.1055/a-1342-2755 Keywords:

Two‐day low‐dose dexamethasone suppression test more accurate than overnight 1‐mg in women taking oral contraceptives


Author(s): Carton T, Mathieu E, Wolff F, Bouziotis J, Corvilain B, Driessens N
Affiliated Institution / ERN: AOUI Verona ;
Condition / Disease: Cushing's syndrome
Publication: Endocrinology, Diabetes & Metabolism v4.3 Year: 2021 ORPHAcode / other: ORPHA553
DOI: 10.1002/edm2.255 Keywords: Cushing's syndrome,dexamethasone suppression test,false positive,oral contraception
MTG1 MTG6

Rate of non-invasive follicular thyroid neoplasms with papillary-like nuclear features depends on pathologist’s criteria: a multicentre retrospective Southern European study with prolonged follow-up


Author(s): Paja M, Zafón C, Iglesias C, Ugalde A, Cameselle-Teijeiro JM, Rodríguez-Carnero G, Fernández-Seara P, Anda E, Povoa A, Quiceno H, Sánchez-Gómez NM, González C, García-Pascual L, Gómez de la Riva I, Blanco C, Meizoso T, Riesco-Eizaguirre G, Capel I, Ortega MV, Mancha I, Chao M, Alcázar V, Roselló E, Maravall J, López-Agulló S, Pérez-Lázaro A, Meseguer P, Sanz J, Paricio JJ, Echeverría S, Castaño Ã, Bella RM
Affiliated Institution / ERN:
Condition / Disease: Follicular thyroid carcinoma
Publication: Endocrine v73.1 p131-140 Year: 2021 ORPHAcode / other: ORPHA146
DOI: 10.1007/s12020-021-02610-7 Keywords: NIFTP,Papillary thyroid carcinoma,Pathologist,Retrospective study,Thyroid neoplasm,WDT-UMP
MTG8

International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers


Author(s): Amar L, Pacak K, Steichen O, Akker SA, Aylwin SJB, Baudin E, Buffet A, Burnichon N, Clifton-Bligh RJ, Dahia PLM, Fassnacht M, Grossman AB, Herman P, Hicks RJ, Januszewicz A, Jimenez C, Kunst HPM, Lewis D, Mannelli M, Naruse M, Robledo M, Taïeb D, Taylor DR, Timmers HJLM, Treglia G, Tufton N, Young WF, Lenders JWM, Gimenez-Roqueplo A, Lussey-Lepoutre C
Affiliated Institution / ERN: Sestre milosrdnice University Hospital Center ; Clinical Psychiatric Hospital "Alexandru Obregia" ; Ulm University Medical Center ; IRCCS Istituto Giannina Gaslini, Genova ; Hospital Universitario Cruces ;
Condition / Disease: Phaeochromocytoma and paraganglioma
Publication: Nature Reviews Endocrinology v17.7 p435-444 Year: 2021 ORPHAcode / other: ORPHA573163
DOI: 10.1038/s41574-021-00492-3 Keywords:
MTG1 MTG4
Page 18 of 30« First«...10...1617181920...30...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance